SWOT Analysis for Natco Pharma Ltd. - Opportunity

Add SWOT widget to your site/app

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

PEG lower than Industry PEG

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Promoter decreasing their shareholding

Oversold by Money Flow Index (MFI)

Performance of Stocks with Low Trendlyne Durability Score versus Benchmarks

Degrowth in Revenue and Profit

Declining Net Cash Flow : Companies not able to generate net cash

Fall in Quarterly Revenue and Net Profit (YoY)

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Increasing Trend in Non-Core Income

RSI indicating price weakness

Top Losers

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Broker price or reco upgrades in last month

Brokers upgraded recommendation or target price in the past three months

Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Broker price or reco upgrades in last month

Red Flags: Weakening Technicals and Share Price Decline

Bullish or Bearish Candlestick Strength - Indices

Big Changes up or down in FII holding

Dragonfly Doji (Bullish Reversal)

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks